Top Markets
Coin of the day
Vanta Bioscience Limited Vanta Bioscience Limited

Vanta Bioscience Limited

VANTABIO
Rank in Stocks #37651
Vanta Bioscience Limited functions as an all-encompassing preclinical contract... Vanta Bioscience Limited functions as an all-encompassing preclinical contract research organization (CRO). The firm extends a wide array of specialized offerings, including Discovery Toxicology, comprehensive assessments for Agro-Chemicals and overall Chemical Safety, Biocompatibility Studies, Diet Formulation, and Batch Release Testing. This company commenced operations on April 29, 2016, and its main office is situated in Hyderabad, India.
Share Price
$0.21674463
Last synced: 2026-08-13
Market Cap
$1.54M
Change (1 day)
-4.98%
Change (1 year)
-25.87%
Country
IN
Trade Vanta Bioscience Limited (VANTABIO)

Category

P/B ratio for Vanta Bioscience Limited (VANTABIO)
P/B ratio as of 2026 TTM: 0
According to Vanta Bioscience Limited latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Vanta Bioscience Limited from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
6.2413 -
NL
- -
CH
- -
KR
3.4612 -
BE